BMY has enjoyed robust capital appreciation over the past few months, significantly aided by the ongoing market rotation to ...

But what it does have is its critical role—albeit underrated—as a biotech hub. Competing with South San Francisco and Boston, ...

Bristol-Myers Squibb Co. has announced it will acquire ... the portfolio we have built to help patients with diabetes by building on the success Amylin has had with its GLP-1 franchise.

Nearly 300 employees in Lawrenceville will lose their jobs as part of a pharmaceutical company's major cost-cutting measures, officials said.Bristol Myers Squibb will lay off at least 290 employees in ...

Bristol Myers Squibb will acquire 2seventy bio for about $286 million in cash, sending the cancer cell therapy maker's shares ...

Bristol Myers Squibb stock (NYSE: BMY) has risen by 7% this year, outperforming the S&P 500 which has fallen by 1%. BMS’s robust Q4 performance has contributed to its positive momentum.

It was revealed Monday that Pharma giant Bristol-Myers Squibb will acquire all outstanding shares of 2seventy bio for $5, valuing the deal at ~$286m. 2seventy bio, a Cambridge-based biotech ...

Dr. Cord Dohrmann, Chief Scientific Officer of Evotec, commented: “This latest achievement further underscores the strength of our collaboration with Bristol Myers Squibb and the impact it has for ...

Bristol Myers Squibb, a leading global biopharmaceutical company, has recently appointed Osama Braiwish as its General ...

Bristol-Myers Squibb's has become the first company to ... HCM who need a procedure called septal reduction therapy (SRT), building its evidence base further. The approval extends BMS' lead ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other Friday’s worst performing stocks. Wall Street’s main indices bounced back on ...

"This latest achievement further underscores the strength of our collaboration with Bristol Myers Squibb and the impact it has for jointly building a strong pipeline in neurological diseases.